Drawing for EPICLICK

USPTO serial 99045530

EPICLICK

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
Examiner
KRAVTSOFF, ELENA V N
Law office
TMO LAW OFFICE 113

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with EPICLICK?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jennifer Insley-Pruitt

Jennifer Insley-Pruitt Dechert LLP1095 Avenue of the AmericasNew York, NY 10036United States

Goods and services

ClassDescriptionStatusFirst use
001biological and chemical solutions and preparations for use in the creation of antibodies and manufacture of therapeutics; biological and chemical solutions and preparations for use in drug development; biological and chemical platforms for use in the creation of antibodies and manufacture of therapeutics; biological platforms for use in drug developmentACTIVE
005pharmaceutical preparations and substances for use in the treatment of cancers and inflammatory and immunological disorders; antibodies for use in the treatment of cancers and inflammatory and immunological disorders; pharmaceutical preparations and substances for use in the creation of antibodiesACTIVE
042research and development in the field of cancers and inflammatory and immunological disorders; research and development in the fields of pharmaceuticals and drug development; pharmaceutical drug development services; providing medical and scientific research information in the fields of pharmaceuticals and drug development; consulting services in the fields of pharmaceuticals and drug development; scientific research; scientific investigations for medical purposes; development of platforms for use in the creation of antibodies and manufacture of therapeutics; providing drug development technology for use in the creation of antibodies and manufacture of therapeuticsACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB2): The trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.

DateCodeEventWhat it means
Feb 9, 2026MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Feb 9, 2026ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Oct 24, 2025EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Oct 24, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Oct 24, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Oct 24, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Oct 24, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Oct 24, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Oct 24, 2025XELGAPPLICATION EXTENSION GRANTED/RECEIPT PROVIDED
Oct 24, 2025XELRAPPLICATION EXTENSION TO RESPONSE PERIOD - RECEIVED
Jul 25, 2025GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 25, 2025GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 25, 2025CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 24, 2025DOCKASSIGNED TO EXAMINER
Jul 15, 2025NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Mar 6, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 6, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 6, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 18, 2025MAFRAPPLICATION FILING RECEIPT MAILED
Feb 18, 2025NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance